GOLDEN SEEDS NEWSLETTER
In our fourth month of the virtualization of everything, we continue to admire the resilience of our many entrepreneurs and the determination of investors to support women-led companies in these uncertain times.  Many organizations are gratified by their ability to adapt and continue on course.  Golden Seeds is no exception.
 
A recent highlight is the recognition of Cognition Therapeutics with a $75.8 million landmark grant for an Alzheimer’s clinical trial. It is a testament to the groundbreaking research being done at Cognition Therapeutics. Read below a conversation with Co-Founder and Chief Science Officer Dr. Susan Catalano and CEO Lisa Ricciardi. Congratulations to this remarkable team.

Many boards of directors have been playing multiple roles to support companies during this challenging time. Golden Seeds Fund Partners Deb Kemper and Kathryn Swintek share their views of many years of board experience in the blog below. And two Golden Seeds Managing Partners, Susan Nethero and David Nethero, founders of our Atlanta chapter, provide advice to entrepreneurs who were planning to launch before COVID changed so much.
 
We are proud to share three recent blogs about Golden Seeds companies. Hello Alice, a Houston company, is matching small businesses with personalized opportunities and resources.  Kinnos, of Brooklyn, is focused on effective disinfection of surfaces.  And CNote, is an Oakland company that provides fixed-income opportunities that support Main Street America – focused on female and minority entrepreneurs.
 
Wishing you good health in this difficult time.
Cognition Therapeutics Receives $75.8M Landmark Grant for Alzheimer’s Clinical Trial
Golden Seeds’ first investment in Cognition Therapeutics was in 2010.  We're continually inspired by their progress, and now this landmark $75.8 million grant for an Alzheimer's clinical trial. This is an interview of Co-Founder and Chief Science Officer Dr. Susan Catalano and CEO Lisa Ricciardi by Peggy Wallace, Golden Seeds Managing Partner and Cognition Therapeutics board member.
 

A call to action: What boards must do to help companies and CEOs cope with the Covid-19 crisis
Board members: Your role as a coach and mentor to your companies’ CEOs has expanded. Do you know how to help your CEOs deal with today’s extreme challenges? Read more below.


I was ready to launch my startup pre-COVID-19: Now what?


Golden Seeds Managing Directors Susan and David Nethero share advice for founders preparing to launch their startup.



How did she do it? A Q&A with Carolyn Rodz, Co-Founder and CEO of Hello Alice

Carolyn Rodz and Elizabeth Gore, founders of Hello Alic e were looking for ways to help small businesses, particularly those in underserved communities, connect to resources they need to accelerate growth.

How did she do it? A Q&A with Katherine Jin, Co-Founder and Chief Technology Officer of Kinnos

Studies have shown that improperly cleaned healthcare surfaces cause unnecessarily high rates of infections. Kinnos Inc, a Golden Seeds company, was created to address that problem.


How did she do it? A Q&A with Catherine Berman, CEO of CNote

While conventional wisdom says you can't make money investing with your conscience, the founder of CNote is proving this adage incorrect. Read more about how this Golden Seeds company came to be - and why.


The early-stage investment firm with a focus on women leaders

Golden Seeds pursues investment returns through the empowerment of women entrepreneurs and those who invest in them. We offer an environment in which exciting women-led businesses receive capital and connections to grow and successfully exit.  The group is headquartered in New York City, with active chapters in Arizona, Atlanta, Boston, Dallas, Houston, New Jersey, and Silicon Valley. One of the largest angel networks in the United States, Golden Seeds has nearly 300 members and has a relationship with three funds with committed capital of $40 million. In total, Golden Seeds has invested nearly $135 million in 193 companies. We aim to achieve market returns for our investors while at the same time creating lasting impact.

If you found this newsletter helpful, share it.
www.go ldensee ds.com